Daniel J. García-Domínguez

Author

Also Known As

D J García-Domínguez, Daniel García-Domínguez, Daniel García‑Domínguez, Daniel J García-Domínguez, Daniel J. Garcia-Dominguez, Daniel J. García-Domínguez, Daniel Jose García-Domínguez, Daniel José García-Domínguez

Publications

724

Citations

H-Index

Concepts

All Affiliations

Universidad de Sevilla Instituto de Biomedicina de Sevilla Hospital Universitario Virgen del Rocío Hospital Sant Joan de Déu Barcelona Imperial College London

About

Daniel J. García-Domínguez is an author at Universidad de Sevilla specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	272
2	Cell Biology	6	6	148
3	Pathology	4	4	150
4	Immunology	2	2	34
5	Health Sciences	1	1	23

Daniel J. García-Domínguez

Publications

391

Citations

H-Index

Page 1

	Year	Citations
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma Carlos Mackintosh, José Luis Ordóñez, Daniel J. García-Domínguez, Oncogene Ewing SarcomaMalignant DiseaseMedicineProliferative FormPathology	2011	114
WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells Carlos Mackintosh, Daniel J. García-Domínguez, José Luis Ordóñez, Oncogene Wee1 AccumulationCell RegulationS-phase ProteinsMedicineEwing Sarcoma Cells	2012	65
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis Sara Sánchez-Molina, Elisabet Figuerola-Bou, Enrique Blanco, Science Advances	2020	30
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma Daniel J. García-Domínguez, Lourdes Hontecillas‐Prieto, Pablo Rodríguez‐Núñez, Oncotarget	2018	29
Stabilization of<i>Dll1</i>mRNA by Elavl1/HuR in neuroepithelial cells undergoing mitosis Daniel J. García-Domínguez, Dominique Morello, Elsa Cisneros, Molecular Biology of the Cell	2011	24
Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer Daniel J. García-Domínguez, Soledad López, Gonzalo Álba, International Journal of Molecular Sciences ImmunologyImmune Cell TherapyImmune SystemImmunotherapyTumor Biology	2024	23
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma Daniel J. García-Domínguez, Nabil Hajji, Sara Sánchez-Molina, Oncogene	2021	21
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1 Daniel J. García-Domínguez, Nabil Hajji, Roser López‐Alemany, Oncogene Histone ModificationsChromatinEwing SarcomaOncologyMedicine	2022	20
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients Lourdes Hontecillas‐Prieto, Daniel J. García-Domínguez, Diego Pascual Vaca, Oncotarget PathologyCancer BiologyMultidrug Resistance TransportersTumor BiologyDrug Resistance	2017	15
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis Natalia Palazón‐Carrión, Alejandro Martı́n, Esteban Nogales‐Fernández, Clinical Cancer Research	2022	15

Page 1